Pfizer on Monday named the former head of the U.S. health regulator's drug evaluation unit, Patrizia Cavazzoni, as its chief ...

Pfizer (PFE) made some major changes to its diversity, equity, and inclusion (DEI) webpage on Thursday, joining other major ...

The former head of the Food and Drug Administration’s (FDA) drug division is joining Pfizer as its chief medical officer, the ...

Pfizer (NYSE:PFE) and GSK (NYSE:GSK) revamp DEI initiatives, emphasizing merit-based diversity amid changing U.S. policies.

Shares of Pfizer Inc. PFE advanced 1.26% to $26.43 Friday, on what proved to be an all-around favorable trading session for ...

Pfizer made changes to its DEI webpage, joining other companies across different industries repositioning their messaging ...

Pfizer partners with Summit Therapeutics to advance cancer treatments using ADCs and ivonescimab. Click here to find out why ...

For decades, women have trusted Depo-Provera, a birth control injection manufactured by Pfizer, as a convenient and effective ...

Cases in Texas and other states are on the rise, but most of the infected were not vaccinated. Here’s what to know about the ...

Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer (PFE – Research Report) yesterday and set a price target of $30.00. The ...

In a report released today, Geoff Meacham from Citi maintained a Hold rating on Pfizer (PFE – Research Report). The company’s shares closed ...

The molecular glue space has attracted several Big Pharma players over the past few years, including Novo Nordisk, Pfizer and ...